|Bid||0.5920 x 1100|
|Ask||0.6000 x 1400|
|Day's Range||0.4600 - 0.5800|
|52 Week Range||0.2500 - 1.7000|
|Beta (5Y Monthly)||2.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.25|
Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, today provided a clinical programs update and reported financial results for the year ended December 31, 2020.
NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Synthetic Biologics, Inc. (NYSE:SYN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 4, 2021 at 4:30 PM Eastern Time.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...